Publication | Closed Access

Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy

NanomedicineEngineeringPolymer-drug ConjugateMedicineTherapeutic NanomaterialsNovel PolyNano-drug DeliveryTumor TargetingBiomedical EngineeringLactic-co-glycolic AcidDrug Delivery SystemOncologyRadiation OncologyCancer ResearchColon Cancer Therapy